Metastatic cutaneous apocrine adenocarcinoma successfully treated with systemic anti‐androgen therapy—A case report

Primary cutaneous apocrine adenocarcinoma (PCAC) is an extremely rare neoplasm involving the sweat glands. Due to a lack of cases, there is no consensus for the systemic treatment of locally advanced or metastatic PCAC. Anti‐androgen therapy may have activity in inoperable or metastatic PCAC with hi...

Descripción completa

Detalles Bibliográficos
Autores principales: Collette, Fanny, Hamoir, Marc, Van Eeckhout, Pascal, D’Abadie, Philippe, Duprez, Thierry, Schmitz, Sandra, Machiels, Jean‐Pascal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752452/
https://www.ncbi.nlm.nih.gov/pubmed/33363954
http://dx.doi.org/10.1002/ccr3.3434
Descripción
Sumario:Primary cutaneous apocrine adenocarcinoma (PCAC) is an extremely rare neoplasm involving the sweat glands. Due to a lack of cases, there is no consensus for the systemic treatment of locally advanced or metastatic PCAC. Anti‐androgen therapy may have activity in inoperable or metastatic PCAC with high androgen receptor (AR) expression.

Ejemplares similares